Text Size
754 studies found for:    Open Studies | "Prostatic Neoplasms"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Prostatic Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Lyophilized Black Raspberry in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions: Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: lyophilized black raspberry lozenge;   Other: laboratory biomarker analysis;   Dietary Supplement: dietary intervention;   Procedure: therapeutic conventional surgery;   Procedure: quality-of-life assessment;   Other: questionnaire administration
2 Recruiting Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
Conditions: Diarrhea;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: cabazitaxel;   Drug: prednisone;   Drug: octreotide pamoate;   Other: questionnaire administration;   Drug: octreotide acetate
3 Recruiting Atorvastatin Calcium in Preventing Metabolic Syndrome in Patients With Prostate Cancer Receiving Long-Term Androgen-Deprivation Therapy
Conditions: Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: atorvastatin calcium;   Drug: placebo
4 Not yet recruiting Cabozantinib in Treating Men With Castration-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Castration-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis
5 Recruiting High-Dose Stereotactic Radiation for Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Radiation: stereotactic body radiation therapy;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
6 Recruiting Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Pain;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: mitoxantrone;   Drug: prednisone
7 Recruiting Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
Conditions: Cancer of the Prostate;   Prostate Cancer;   Prostatic Neoplasms
Interventions: Dietary Supplement: Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E;   Drug: Placebo
8 Recruiting Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Pain;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: prednisone
9 Recruiting Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer;   Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: vorinostat;   Drug: temsirolimus;   Other: laboratory biomarker analysis;   Procedure: positron emission tomography/computed tomography
10 Recruiting Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Prostate Cancer;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration;   Drug: doxorubicin-GnRH agonist conjugate AEZS-108
11 Recruiting Genistein in Treating Patients With Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage II Prostate Cancer;   Stage III Prostate Cancer
Interventions: Dietary Supplement: genistein;   Other: placebo;   Procedure: therapeutic conventional surgery
12 Recruiting High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer;   Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
Interventions: Radiation: Brachytherapy;   Radiation: Stereotactic Body Radiation Therapy;   Procedure: Quality-of-life assessment;   Other: Questionnaire administration
13 Recruiting Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
Interventions: Radiation: brachytherapy;   Radiation: image-guided radiation therapy;   Other: laboratory biomarker analysis
14 Recruiting Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Conditions: Adenocarcinoma of the Prostate;   Stage I Prostate Cancer;   Stage II Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Dietary Supplement: cholecalciferol;   Drug: placebo administration;   Other: active surveillance;   Other: laboratory biomarker analysis
15 Recruiting Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
Interventions: Drug: metformin hydrochloride;   Other: placebo;   Other: laboratory biomarker analysis
16 Recruiting Sipuleucel-T Manufacturing Demonstration Study
Conditions: Cancer of Prostate;   Cancer of the Prostate;   Neoplasms, Prostate;   Neoplasms, Prostatic;   Prostate Cancer;   Prostate Neoplasms;   Prostatic Cancer
Intervention: Biological: sipuleucel-T
17 Recruiting Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
Conditions: Metastatic Prostate Cancer;   Cancer of the Prostate;   Prostate Cancer
Interventions: Drug: Anti-OX40;   Radiation: Radiation;   Drug: Cyclophosphamide
18 Recruiting Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Stage I Prostate Cancer;   Stage II Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Intervention: Radiation: intensity modulated external beam radiation therapy
19 Unknown † Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
Conditions: Cancer of the Prostate;   Prostate Cancer;   Prostatic Neoplasms
Interventions: Dietary Supplement: Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E;   Drug: Placebo
20 Recruiting Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
Conditions: Castrate Resistant Prostate Cancer;   Chemotherapy Naive Prostate Cancer;   Prostate Cancer
Interventions: Drug: Pasireotide;   Drug: Everolimus;   Other: Laboratory biomarker analysis
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years